Did you mean acetaminophen of aspirina and non ibuprofen?
Displaying drugs 13951 - 13975 of 14792 in total
Ferric oxyhydroxide
An antiferromagnetic material; constitutes the core of natural ferritin.
Experimental
Matched Description: … An antiferromagnetic material; constitutes the core of natural ferritin. …
Sarconeos
Sarconeos is an activator of the MAS receptor.
Investigational
Matched Description: … Sarconeos is an activator of the MAS receptor. …
MIV-701
MIV-701 is a selective, potent inhibitor of the protease Cathepsin K. It is developed for the treatment of osteoporosis.
Investigational
Matched Description: … It is developed for the treatment of osteoporosis. ... MIV-701 is a selective, potent inhibitor of the protease Cathepsin K. …
Nevanimibe
Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
Investigational
Matched Description: … of Endogenous Cushing's Syndrome). ... Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment …
Daxalipram
Experimental
2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid
Experimental
(R)-Atenolol
Experimental
GLPG-0492
Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Investigational
Matched Description: … Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of …
Daniquidone
Daniquidone has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … Daniquidone has been used in trials studying the treatment of Neoplasms. …
CHS-828
CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific …
IDM-1
IDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.
Investigational
Matched Description: … IDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. ... It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific …
7-Deazaguanine
Experimental
Displaying drugs 13951 - 13975 of 14792 in total